The A-share biopharmaceutical sector continues to strengthen, with Maccura, Hybribio Biotech, and KHB hitting the daily limit up in the afternoon. LIFERIVER and DAJY had previously reached their limit up, while WONDFO BIOTECH, ACROBIOSYSTEMS, Orient Biotech, and SSSW rose over 10%Wallstreetcn·Jan 25 at 11:15 PM688317+1.19%002022+0.79%
Orient Biotech's subsidiary has obtained registration certificates for two medical device productsZhitong·Sep 22, 2025 at 03:13 AM688298+2.44%
Orient Biotech: Completed the repurchase of 1.8013 million sharesZhitong·Sep 11, 2025 at 06:18 AM688298+2.44%
Orient Biotech's subsidiary obtains medical device registration certificateZhitong·Sep 9, 2025 at 04:17 AM688298+2.44%
Orient Biotech: Net loss of 163 million yuan in the first half of 2025Zhitong·Aug 28, 2025 at 06:49 AM688298+2.44%
Institutional Deployment: Structural Opportunities Become Market ConsensusZhitong·Jul 16, 2025 at 05:42 PM688313+7.23%688298+2.44%
Famous fund managers' second-quarter portfolio adjustments revealed: increasing positions in military industry, with divergences in the pharmaceutical sectorZhitong·Jul 8, 2025 at 08:41 AM688298+2.44%688062+0.46%
Famous fund manager's portfolio adjustment revealed, intensively participating in the medical and military sectorsZhitong·Jul 6, 2025 at 05:57 PM301033+1.80%688298+2.44%
Orient Biotech plans to repurchase shares for 25 million to 50 million yuanZhitong·Jun 27, 2025 at 04:44 AM688298+2.44%
Orient Biotech has obtained a medical device registration certificateZhitong·Jun 23, 2025 at 04:06 AM688298+2.44%
Orient Biotech and its subsidiaries have obtained multiple medical device registration certificatesZhitong·Jun 18, 2025 at 03:50 AM688298+2.44%
Orient Biotech: The chairman proposed to repurchase shares not exceeding 50 million yuanZhitong·Jun 17, 2025 at 04:48 AM688298+2.44%
Orient Biotech: Net loss of 115 million yuan in the first quarter of 2025Zhitong·Apr 29, 2025 at 09:15 AM688298+2.44%
